WebSep 24, 2024 · Cisplatin (CDDP) is the drug of choice against different types of cancer. However, tumor cells can acquire resistance to the damage caused by cisplatin, generating genetic and epigenetic changes that lead to the generation of resistance and the activation of intrinsic resistance mechanisms in cancer cells. Among them, we can find mutations, … WebCisplatin is a chemotherapy drug that contains the metal platinum. It stops or slows growth of cancer cells and other cells that grow rapidly by damaging their DNA. FDA Approved …
Barnett Rosenberg - Wikipedia
WebSep 30, 2024 · In 1978, it was approved by the US Food and Drug Administration (FDA) as an anticancer treatment for patients with testicular and bladder cancer. Since then, … WebApr 11, 2024 · Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of ... try silver hair filter
Michele Peyrone (1813–1883), Discoverer of Cisplatin
WebCisplatin, a class of platinum-containing anticancer drugs for the treatment of solid tumors, is a substrate of OCT2 and MATE1/MATE2-K. OCT2 is expressed in the basolateral membrane of proximal tubules and mediates the transport of cisplatin from the blood to proximal tubule cells. WebOct 30, 2024 · This study shows that cisplatin resistance can occur by a non-genetic mechanism in the TME in which CAFs regulate thiol metabolism, thereby impairing … WebCisplatin 9. The Discovery - One Scientist's Story ChemCases Kennesaw State University References As we saw in the role of platinum electrodes module, the researchers found that certain transition metal complexes—specifically, soluble metal salts—caused elongation of E. coli bacterial cells. phillip private equity pte ltd